MRI, MRS scans reveal who will lose weight
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes.
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes. Study subjects whose health improved the most after lifestyle changes started out with lower baseline levels of abdominal and liver fat.
German researchers performed MRI and MR spectroscopy on 243 individuals prior to and nine months after a lifestyle intervention (weight loss of 5%, reduced fat intake, and moderate physical activity). Each of the participants was considered at risk of developing type 2 diabetes as a result of obesity.
After nine months, insulin sensitivity improved in 71% of the men and 58% of the women. Individuals with improved insulin sensitivity lost significant amounts of abdominal fat (19% for women and 20% for men) and liver fat (35% for women and 44% for men) (Radiol doi:10.1148/radiol.10092284).
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
